Invention Grant
US08426400B2 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
有权
β-内酰胺基苯丙氨酸，半胱氨酸和丝氨酸加压素拮抗剂
- Patent Title: β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
- Patent Title (中): β-内酰胺基苯丙氨酸，半胱氨酸和丝氨酸加压素拮抗剂
-
Application No.: US13285590Application Date: 2011-10-31
-
Publication No.: US08426400B2Publication Date: 2013-04-23
- Inventor: Gary A. Koppel , Marvin J. Miller
- Applicant: Gary A. Koppel , Marvin J. Miller
- Applicant Address: US PA Bethlehem
- Assignee: Azevan Pharmaceuticals, Inc.
- Current Assignee: Azevan Pharmaceuticals, Inc.
- Current Assignee Address: US PA Bethlehem
- Agency: Barnes & Thornburg LLP
- Main IPC: C07D205/085
- IPC: C07D205/085 ; A61K31/397 ; C07D403/04 ; C07D413/04 ; A61P25/22
Abstract:
Substituted 2-(azetidin-2-on-1-yl)alkoxyalkylalkanoic acids and 2-(azetidin-2-on-1-yl)arylalkylalkanoic acids, and analogs and derivatives thereof are described. Methods for using the described compounds, and pharmaceutical compositions thereof, to treat disease states responsive to antagonism of one or more vasopressin receptors are also described.
Public/Granted literature
- US20120220765A1 BETA-LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE VASOPRESSIN ANTAGONISTS Public/Granted day:2012-08-30
Information query
